 "Biocon surges 5% on bonus issue plan")
Biocon rallied 5.5% to Rs 1,125 on BSE in early morning trade after the company said that the board will consider issue of bonus shares in their meeting held on Thursday, April 27, 2017.
Earlier on March 30, the company engaged in biotechnology business had said a meeting of the board of directors of the company will be held on April 27, 2017, to consider, approve and take on record, the audited financial results (both standalone and consolidated) of the company for the year ended March 31, 2017.
On April 20, Biocon said the board will also consider and recommend a final dividend, if any, for the financial year 2016-17.
On Monday, it said “we wish to inform you that, consideration and recommendation to issue bonus shares forms part of the agenda of the meeting of board of directors of the company, scheduled on Thursday, April 27, 2017.”
So far in 2017, the stock had performed in line with the market, which gaining around 12% till yesterday.
At 9:27 am; it was up 5% at Rs 1,121 on BSE as compared to 0.54% rise in the S&P BSE Sensex. A combined 292,094 shares changed hands on the counter on BSE and NSE so far.
Earlier on March 30, the company engaged in biotechnology business had said a meeting of the board of directors of the company will be held on April 27, 2017, to consider, approve and take on record, the audited financial results (both standalone and consolidated) of the company for the year ended March 31, 2017.
On April 20, Biocon said the board will also consider and recommend a final dividend, if any, for the financial year 2016-17.
On Monday, it said “we wish to inform you that, consideration and recommendation to issue bonus shares forms part of the agenda of the meeting of board of directors of the company, scheduled on Thursday, April 27, 2017.”
So far in 2017, the stock had performed in line with the market, which gaining around 12% till yesterday.
At 9:27 am; it was up 5% at Rs 1,121 on BSE as compared to 0.54% rise in the S&P BSE Sensex. A combined 292,094 shares changed hands on the counter on BSE and NSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%